Adult Vaccination Recommendations
All adults should receive annual influenza vaccination, a one-time Tdap dose followed by Td boosters every 10 years, and age-appropriate pneumococcal, zoster, and other vaccines based on specific risk factors and age groups. 1, 2
Universal Vaccines for All Adults
Influenza Vaccination
- Annual vaccination required for all adults ≥19 years with inactivated (IIV), recombinant (RIV), or live attenuated (LAIV) formulations 1, 2
- Trivalent formulations are now standard (updated from quadrivalent) 1
- LAIV contraindicated in pregnancy and immunocompromised patients 3
Tetanus, Diphtheria, Pertussis (Tdap/Td)
- One-time Tdap dose for all adults who haven't received it, then Td or Tdap booster every 10 years 3, 1
- Pregnant women: Tdap during EACH pregnancy, preferably weeks 27-36 3
- Critical pitfall: Many providers forget the pregnancy dose—this protects newborns through passive immunity
Age-Based Vaccination Schedule
Ages 19-26 Years
- HPV vaccine: 2-3 doses depending on age at initiation (catch-up through age 26) 3, 1
- MMR: 1-2 doses if born in 1957 or later without evidence of immunity 3
- Varicella: 2 doses if born in 1980 or later without evidence of immunity 3
Ages 27-49 Years
- HPV: May be offered ages 27-45 based on shared clinical decision-making 4, 1
- Continue routine Td/Tdap and annual influenza
Ages 50-64 Years
Ages ≥65 Years
Pneumococcal vaccination—this has evolved significantly:
- 2024-2025 guidance: PCV13 no longer routinely recommended for all adults ≥65 4, 1
- PPSV23: One dose universally recommended at age ≥65 4
- PCV13: Based on shared clinical decision-making for immunocompetent adults ≥65 4
- Higher-risk groups (nursing home residents, chronic conditions, smokers) may benefit more from PCV13 4
RSV vaccine: New recommendation for adults ≥75 years (universal); ages 60-74 with risk factors 1, 2
Risk-Based Vaccinations
Immunocompromised Patients (HIV, transplant, immunosuppressive therapy, asplenia)
Critical timing: Vaccinate at least 2 weeks before planned immunosuppression; avoid during active chemotherapy/radiation 5
Pneumococcal: PCV13 followed by PPSV23 at least 8 weeks later 5, 3
Meningococcal: 2 doses MCV4 at least 2 months apart for asplenia or complement deficiencies 5
HIV patients: Vaccinate as soon as possible after diagnosis 5
Live vaccines (MMR, varicella, ZVL, LAIV): CONTRAINDICATED 3
Chronic Medical Conditions
Ages 19-64 with chronic heart/lung disease, diabetes, chronic liver disease, alcoholism, or smoking:
Hepatitis Vaccination
Hepatitis A (2-3 doses depending on vaccine): 3
- Chronic liver disease
- Clotting factor disorders
- Men who have sex with men
- Injection drug users
- Travel to endemic areas
Hepatitis B (2-3 doses depending on vaccine): 3, 6
- All diabetics ≤60 years 7
- End-stage renal disease/hemodialysis (special high-dose formulation: 40 µg/mL or double 20 µg/mL dose) 6
- HIV infection
- Chronic liver disease
- Men who have sex with men
- Injection drug users
- Healthcare personnel
- Note: Heplisav-B contraindicated in pregnancy (no safety data) 3
Meningococcal Vaccination
MenACWY (1-2 doses, boosters every 5 years if risk persists): 5, 3
- Asplenia or complement deficiencies (2 doses, 2 months apart)
- HIV infection (2 doses)
- Microbiologists exposed to N. meningitidis
- Travel to hyperendemic areas
- First-year college students in dorms through age 21 (if not vaccinated after age 16)
MenB (2-3 doses depending on vaccine): 1, 2
- Ages 16-23 (preferred 16-18) based on shared clinical decision-making
- Asplenia, complement deficiencies (required, not optional)
Healthcare Personnel
- Annual influenza 3
- Tdap (if not previously received) 3
- MMR: 2-dose series if born in 1957 or later 3
- Varicella: 2 doses if no evidence of immunity 3
- Hepatitis B: 3-dose series 6
Critical Timing Considerations
Elective splenectomy: Vaccinate ≥2 weeks before surgery 5, 6
Immunosuppressive therapy: Vaccinate ≥2 weeks before initiation 5
PPSV23 revaccination:
- One-time revaccination 5 years after first dose for ages 19-64 with renal failure, asplenia, or immunocompromising conditions 5
- If received PPSV23 before age 65: Give another dose at ≥65 if ≥5 years since last dose 5
- No further doses needed if vaccinated at/after age 65 5
Common Pitfalls to Avoid
- Forgetting Tdap in every pregnancy—this is the single most missed vaccine in practice
- Not checking vaccination status in immunocompromised patients before starting therapy—once on chemotherapy, it's too late for many vaccines
- Assuming older adults are "caught up"—many need MMR, varicella if born after certain years
- Missing the PCV13/PPSV23 sequencing—order matters for immunocompromised patients
- Not offering HPV vaccine to adults through age 26—catch-up is still beneficial
- Giving live vaccines to immunocompromised patients—can cause severe disease